-
公开(公告)号:US20090163493A9
公开(公告)日:2009-06-25
申请号:US11959784
申请日:2007-12-19
申请人: Kenneth Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
发明人: Kenneth Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
IPC分类号: A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61P19/02 , A61P25/00 , A61P29/00 , A61P3/00 , A61P31/00 , A61P35/00 , A61P37/00 , A61P9/00 , C07D209/08 , C07D231/56 , C07D401/02 , C07D405/02 , C07D409/02 , C07D413/02
CPC分类号: C07D409/12 , A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K45/00 , A61K45/06 , A61N5/10 , C07D209/08 , C07D209/14 , C07D231/54 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,n,Q1,Q2,Q3,Y和X1-X4如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20070185184A1
公开(公告)日:2007-08-09
申请号:US11532340
申请日:2006-09-15
申请人: Gunnar Hanson , Thomas Barta , Lifeng Geng , James Veal , Kenneth Huang
发明人: Gunnar Hanson , Thomas Barta , Lifeng Geng , James Veal , Kenneth Huang
IPC分类号: A61K31/403 , C07D209/82
CPC分类号: C07D209/88 , C07D209/12 , C07D209/14 , C07D401/12 , C07D471/04
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I: wherein n, R1, R2, R3, X, R4, R5, R6, R8, R9, and Y are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation and/or abnormal cell mitosis, such as cancer, inflammation and inflammation-associated disorders, and conditions associated with angiogenesis. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐:其中n,R 1,R 2,R 3,X,R 1, R 5,R 5,R 6,R 8,R 9和Y分别为 本文定义。 式I的化合物可用于治疗与细胞增殖和/或异常细胞有丝分裂相关的疾病和/或病症,例如癌症,炎症和炎症相关疾病以及与血管发生相关的病症。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20060211737A1
公开(公告)日:2006-09-21
申请号:US11363449
申请日:2006-02-27
申请人: Kenneth Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
发明人: Kenneth Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
IPC分类号: A61K31/4439 , A61K31/4162 , A61K31/404 , C07D403/02 , C07D405/02 , C07D409/02
CPC分类号: C07D409/12 , A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K45/00 , A61K45/06 , A61N5/10 , C07D209/08 , C07D209/14 , C07D231/54 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和可药用盐,其中R 1,R 2,R 3,R 4, R 5,R 6,R 7,n,Q 1,Q 2, 3,Q 3,Y和X 1 -X 4个如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US08309548B2
公开(公告)日:2012-11-13
申请号:US13081637
申请日:2011-04-07
申请人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
发明人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
IPC分类号: A61K31/5377 , A61K31/454 , A61K31/415 , A61K31/405 , C07D413/12 , C07D401/12 , C07D403/12 , C07D209/04
CPC分类号: C07D409/12 , A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K45/00 , A61K45/06 , A61N5/10 , C07D209/08 , C07D209/14 , C07D231/54 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,n,Q1,Q2,Q3,Y和X1-X4如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US07906529B2
公开(公告)日:2011-03-15
申请号:US11959784
申请日:2007-12-19
申请人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
发明人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
IPC分类号: C07D209/00 , A01N43/42
CPC分类号: C07D409/12 , A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K45/00 , A61K45/06 , A61N5/10 , C07D209/08 , C07D209/14 , C07D231/54 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中R1,R2,R3,R4,R5,R6,R7,n,Q1,Q2,Q3,Y和X1-X4如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US20080096887A1
公开(公告)日:2008-04-24
申请号:US11959784
申请日:2007-12-19
申请人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
发明人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
IPC分类号: A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61P19/02 , A61P25/00 , A61P29/00 , A61P3/00 , A61P31/00 , A61P35/00 , A61P37/00 , A61P9/00 , C07D209/08 , C07D231/56 , C07D401/02 , C07D405/02 , C07D409/02 , C07D413/02
CPC分类号: C07D409/12 , A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K45/00 , A61K45/06 , A61N5/10 , C07D209/08 , C07D209/14 , C07D231/54 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式I的化合物和药学上可接受的盐,其中R 1,R 2,R 3,R 4, R 5,R 6,R 7,n,Q 1,Q 2, 3,Q 3,Y和X 1 -X 4个如本文所定义。 式I化合物可用于治疗与细胞增殖相关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
公开(公告)号:US07928135B2
公开(公告)日:2011-04-19
申请号:US12907571
申请日:2010-10-19
申请人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
发明人: Kenneth He Huang , Jeron Eaves , Gunnar Hanson , James Veal , Thomas Barta , Lifeng Geng , Lindsay Hinkley
IPC分类号: C07D231/54 , A01N43/56
CPC分类号: C07D409/12 , A61K31/404 , A61K31/416 , A61K31/4439 , A61K31/454 , A61K31/5377 , A61K45/00 , A61K45/06 , A61N5/10 , C07D209/08 , C07D209/14 , C07D231/54 , C07D231/56 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R1, R2, R3, R4, R5, R6, R7, n, Q1, Q2, Q3, Y, and X1-X4 are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
-
公开(公告)号:US20070207984A1
公开(公告)日:2007-09-06
申请号:US11678975
申请日:2007-02-26
申请人: Kenneth Huang , Jeron Eaves , James Veal , Steven Hall , Thomas Barta , Gunnar Hanson
发明人: Kenneth Huang , Jeron Eaves , James Veal , Steven Hall , Thomas Barta , Gunnar Hanson
IPC分类号: A61K31/675 , C07D231/56 , C07D209/02 , A61K31/405
CPC分类号: C07D209/08 , C07D231/56
摘要: Disclosed are compounds and pharmaceutically acceptable salts of Formula (I), wherein Q1, Q2, RN, R1, R2, R5, R6, R7, R8, X1, X2, X4, and Y are as defined herein. Compounds of Formula (I) are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
摘要翻译: 公开了式(I)的化合物和药学上可接受的盐,其中Q 1,Q 2,R N,R 1, R 2,R 5,R 6,R 7,R 8, X 1,X 2,X 4和Y如本文所定义。 式(I)的化合物可用于治疗与细胞增殖有关的疾病和/或病症,例如癌症,炎症,关节炎,血管生成等。 还公开了包含本发明化合物的药物组合物和使用这些化合物治疗上述病症的方法。
-
9.
公开(公告)号:US20060035901A1
公开(公告)日:2006-02-16
申请号:US11186404
申请日:2005-07-21
申请人: Gunnar Hanson , Thomas Barta , James Veal , Roy Ware
发明人: Gunnar Hanson , Thomas Barta , James Veal , Roy Ware
IPC分类号: C07D475/02 , A61K31/525
CPC分类号: C07D487/04 , C07D475/04 , C07D475/08 , G01N33/5011 , G01N2333/9015
摘要: The present invention provides novel derivatives of MTX. The novel derivatives have increased selectivity, inhibit the activity of Her2, EGFR, or B-Raf to a greater degree than MTX, and display greater antiproliferative activity than MTX. Also provided are pharmaceutical compositions containing the novel derivatives, to methods of preparation of such derivatives, to methods of inhibiting the biological activity of polypeptides, methods of inhibiting cell proliferation, and the use of the novel compounds in therapy, particularly for the treatment of neoplastic, hyperproliferative, and immune disorders, including cancer, arthritis, and psoriasis.
摘要翻译: 本发明提供MTX的新型衍生物。 新型衍生物具有增加的选择性,抑制Her2,EGFR或B-Raf的活性比MTX更大程度,并且显示比MTX更大的抗增殖活性。 还提供了含有新衍生物的药物组合物,这些衍生物的制备方法,抑制多肽的生物学活性的方法,抑制细胞增殖的方法,以及新型化合物在治疗中的用途,特别是用于治疗肿瘤 ,过度增殖和免疫疾病,包括癌症,关节炎和牛皮癣。
-
公开(公告)号:US20070078146A1
公开(公告)日:2007-04-05
申请号:US10840734
申请日:2004-05-05
申请人: Ashok Naraian , Michael Clare , Paul Collins , Joyce Crich , Rajesh Devraj , Daniel Flynn , Lifeng Geng , Matthew Graneto , Cathleen Hanau , Gunnar Hanson , Susan Hartmann , Michael Hepperle , He Huang , Ish Khanna , Francis Koszyk , Shuyuan Liao , Suzanne Metz , Win Naing , Richard Partis , Thao Perry , Shashidhar Rao , Shaun Selness , Michael South , Michael Stealey , John Talley , Michael Vazquez , John Walker , Richard Weier , Xiangdong Xu , Syaulan Yang , Yi Yu
发明人: Ashok Naraian , Michael Clare , Paul Collins , Joyce Crich , Rajesh Devraj , Daniel Flynn , Lifeng Geng , Matthew Graneto , Cathleen Hanau , Gunnar Hanson , Susan Hartmann , Michael Hepperle , He Huang , Ish Khanna , Francis Koszyk , Shuyuan Liao , Suzanne Metz , Win Naing , Richard Partis , Thao Perry , Shashidhar Rao , Shaun Selness , Michael South , Michael Stealey , John Talley , Michael Vazquez , John Walker , Richard Weier , Xiangdong Xu , Syaulan Yang , Yi Yu
IPC分类号: A61K31/506 , A61K31/4439 , C07D43/02
CPC分类号: C07D401/14 , C07D401/04 , C07D403/04 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/08 , C07D473/00 , C07D487/04 , C07D491/10 , C07D495/04
摘要: A class of pyrazole derivatives is described for use in treating p38 kinase medicated disorders. Compounds of particular interest are defined by Formula IA wherein R1, R2, R3 and R4 are as described in the specification.
摘要翻译: 描述了一类吡唑衍生物用于治疗p38激酶药物障碍。 特别感兴趣的化合物由式IA定义,其中R 1,R 2,R 3和R 4是 如说明书中所述。
-
-
-
-
-
-
-
-
-